Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Visual layout tweaks (spacing and header styling) appear in the screenshots, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:23:27.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated page to v3.2.0 with a new government-operating-status notice; removed the resource for Differentiated thyroid carcinoma from the Genetic and Rare Diseases Information Center.
    Difference
    3%
    Check dated 2025-10-05T10:36:13.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page has been updated to include new dates, a EU Trial CTIS number, revision version, and update indicators, while several historical safety-related sections and older update references were removed. Overall, the changes mainly update metadata and identifiers rather than core content.
    Difference
    1%
    Check dated 2025-09-28T03:27:31.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    - Revision updated from v3.0.1 to v3.0.2; removed the Back to Top link.
    Difference
    0.1%
    Check dated 2025-09-13T17:39:23.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-06T15:18:56.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous specific locations and facility names across various countries, as well as the introduction of new medical terms related to drug safety and thyroid cancer. Notably, the previous version's references to certain locations and terms have been removed.
    Difference
    21%
    Check dated 2025-08-30T11:56:55.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.